Feb 7, 2019
Data speaks volumes: SPACs continue to be an attractive vehicle
Market interest remains strong, with positive IPO vital signs
Tech, biotech and healthcare companies continue to be prime targets, but for how long?
© DealFlow Financial Products, Inc. (d/b/a DealFlow Events). All rights reserved. DealFlow Events(tm) and The SPAC Conference(tm) are trademarks of DealFlow Financial Products, Inc.